The findings appeared in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Researchers at the University of Cincinnati evaluated the use of escitalopram for pediatric anxiety disorders.
In their findings, published in the peer-reviewed journal Child Development, researchers initiated experiments on 96 children at nine months old.
As part of a randomized clinical trial, assessing the effectiveness of either melatonin or the placebo occurred after 28 days of treatment.
Conducted by a group of researchers at the University of California, Los Angeles, they initiated electroencephalography tests on 65 infants at 3 months old.
The findings showed that children who experienced long-term sleep problems exhibited the greatest academic and psychosocial impairments.